Current status and perspectives on vaccine development against dengue virus infection
J Park, J Kim, YS Jang - Journal of Microbiology, 2022 - Springer
Dengue virus (DENV) consists of four serotypes in the family Flaviviridae and is a causative
agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is …
agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is …
Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies
Background: Nearly half of the world is at risk of developing dengue infection. Dengue virus
is the causative agent behind this public healthcare concern. Millions of dengue cases are …
is the causative agent behind this public healthcare concern. Millions of dengue cases are …
Dengue virus vaccine development
LE Yauch, S Shresta - Advances in virus research, 2014 - Elsevier
Dengue virus (DENV) is a significant cause of morbidity and mortality in tropical and
subtropical regions, causing hundreds of millions of infections each year. Infections range …
subtropical regions, causing hundreds of millions of infections each year. Infections range …
Vaccines for the prevention of dengue: development update
SJ Thomas, TP Endy - Human vaccines, 2011 - Taylor & Francis
The dengue viruses (DENV) are mosquito-borne flaviviruses which cause a spectrum of
clinical disease known as “dengue,” and have emerged and re-emerged as a significant …
clinical disease known as “dengue,” and have emerged and re-emerged as a significant …
[HTML][HTML] Targets and strategies for vaccine development against dengue viruses
WH Wang, AN Urbina, CY Lin, ZS Yang… - Biomedicine & …, 2021 - Elsevier
Dengue virus (DENV) is a global health threat causing about half of the worldwide
population to be at risk of infection, especially the people living in tropical and subtropical …
population to be at risk of infection, especially the people living in tropical and subtropical …
Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art
J Pintado Silva… - Journal of General …, 2023 - microbiologyresearch.org
Dengue virus (DENV) is the mosquito-borne virus of greatest human health concern. There
are four serotypes of DENV (1-4) that co-circulate in endemic areas. Each serotype of DENV …
are four serotypes of DENV (1-4) that co-circulate in endemic areas. Each serotype of DENV …
Dengue vaccines: challenges, development, current status and prospects
Infection with dengue virus (DENV) is the most rapidly spreading mosquito-borne viral
disease in the world. The clinical spectrum of dengue, caused by any of the four serotypes of …
disease in the world. The clinical spectrum of dengue, caused by any of the four serotypes of …
Current progress in dengue vaccines
Dengue is one of the most important emerging vector-borne viral diseases. There are four
serotypes of dengue viruses (DENV), each of which is capable of causing self-limited …
serotypes of dengue viruses (DENV), each of which is capable of causing self-limited …
Prospects for a dengue virus vaccine
SS Whitehead, JE Blaney, AP Durbin… - Nature Reviews …, 2007 - nature.com
The number of cases of severe dengue disease continues to grow in endemic areas of
southeast Asia, Central and South America, and other subtropical regions. Children bear the …
southeast Asia, Central and South America, and other subtropical regions. Children bear the …
Dengue vaccine: priorities and progress
MG Guzman, M Muné, G Kourí - Expert Review of Anti-Infective …, 2004 - Taylor & Francis
Dengue transmission has increased considerably in the past 20 years. Currently, it can only
be reduced by mosquito control; however, the application of vector-control methods are …
be reduced by mosquito control; however, the application of vector-control methods are …